In the present study, using genetic and pharmacological methods, we demonstrated that the protective effect of honokiol on NASH and its related metabolic diseases is dependent on AMPK activation. The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatohepatitis.